AllianceBernstein’s Milestone Scientific MLSS Stock Holding History

AllianceBernstein’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,600	Closed	-$21K	–	3189
2020 Q2	$21K	Buy	+10,600	New	+$19.4K	﹤0.01%	3188

Other funds holding MLSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AllianceBernstein's MLSS Position: Q3 2020 in Review

AllianceBernstein sold out of Milestone Scientific (MLSS) in Q3 2020, closing a stake of 10,600 shares — an estimated $21K sold.

AllianceBernstein first reported a position in MLSS in Q2 2020 and held it in 1 quarter. The position peaked at $21K in Q2 2020. 47 funds tracked by Wall St. Rank hold MLSS as of Q3 2020.

AllianceBernstein reported no remaining Milestone Scientific position as of Q3 2020 after selling out during the quarter.
AllianceBernstein sold 10,600 Milestone Scientific shares in Q3 2020, an estimated $21K.
AllianceBernstein first reported a position in Milestone Scientific in Q2 2020 and held it in 1 quarter.
AllianceBernstein's Milestone Scientific position peaked at $21K in Q2 2020.
47 funds tracked by Wall St. Rank held Milestone Scientific as of Q3 2020.

Based on AllianceBernstein's 13F filing for Q3 2020, filed 12 Nov 2020.